• Skip to the Main Content
  • Skip to the Main Navigation
  • Skip to Meta navigation / Search box
cbg-meb

The Medicines Evaluation Board (MEB) assesses and monitors the efficacy, risks and quality of human and veterinary medicinal products. It also assesses the safety of novel foods for human consumption.

FAQ | Medicine database

search

Vervolg zonder link opsomming contact | nederlands | links | site map

College ter Beoordeling van Geneesmiddelen Medicines Evaluation Board

Vervolg zonder link opsomming
  • About MEB
  • Human Medicines
  • Veterinary Medicines
  • Novel Foods
  • July 13
    G.J. Schefferlie chosen as vice-chairman CVMP
  • July 1
    Rheumatologist and pharmacologist with European experience augment the Medicines Evaluation Board
  • June 3
    Annual Report 2009 available

ISO 9001:2000 is erkend door de raad voor de accreditatie

MEB: member of the European Network of Medicines Authorities

  • August 30
    Suspension of medicinal products containing cyclosporine
  • August 26
    Publication on investigation into the implementation of pregnancy prevention programmes for isotretinoin in Europe
  • August 20
    20 August 2010 – Monthly update: state of affairs concerning backlogs
  • August 2
    Authorisation of veterinary medicinal products in the first half of 2010
  • July 22
    New veterinary medicines regulations lead to savings for businesses
  • April 12
    Ministers Verburg and Klink announce measures to combat antibiotic resistance
  • April 28
    Published: assessment of Bovine lactoferrin
  • April 9
    Second assessment report on Yeast β-glucans published
Press & Publications
Information bank for people
Information bank for animals
Evaluation
ISO 9001:2008 | privacy | disclaimer